NCT04630665

Buccal Bone Resorption in Immediate Implants in Thin and Thick Buccal Plates of Bone in Esthetic Zone

Completed NA Last updated 23 February 2024

What this trial tests

NA trial testing immediate implant placement in Buccal Bone Thickness in 18 participants. Completed in 2 November 2022.

Timeline

23 January 2019

Primary endpoint
2 November 2022

2 November 2022

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	18
Start date	23 January 2019
Primary completion	2 November 2022
Estimated completion	2 November 2022
Sites	1 location across Egypt

Drugs / interventions tested

• immediate implant placement

Conditions studied

• Buccal Bone Thickness — all drugs for Buccal Bone Thickness →

Sponsor

Cairo University

Who can join

Adults 18 to 50, any sex, with Buccal Bone Thickness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To achieve esthetic immediate implants a minimum of adequate buccal bone thickness must be present. It was postulated that 2 mm of buccal bone thickness was needed to prevent recession of the buccal plate. However, this was reduced to 1 mm with more ongoing research. In a recent study postulated that a buccal bone thickness less than 1 mm could be sufficient.

Scarce literature was found that monitored the ridge alterations following implant placement.

In regards to the controversies regarding the minimal initial buccal bone thickness required to perform immediate implant placement, our study aims to monitor the buccal bone thickness and soft tissue changes over a year from implant and prosthetic placement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.